Checchi Capital Advisers’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $238K | Buy |
922
+7
| +0.8% | +$1.81K | 0.01% | 510 |
|
2025
Q1 | $205K | Buy |
915
+8
| +0.9% | +$1.79K | 0.01% | 546 |
|
2024
Q4 | $207K | Sell |
907
-10
| -1% | -$2.29K | 0.01% | 539 |
|
2024
Q3 | $224K | Buy |
+917
| New | +$224K | 0.01% | 524 |
|
2023
Q3 | – | Sell |
-1,664
| Closed | -$364K | – | 571 |
|
2023
Q2 | $364K | Buy |
1,664
+18
| +1% | +$3.93K | 0.03% | 361 |
|
2023
Q1 | $360K | Buy |
1,646
+16
| +1% | +$3.5K | 0.03% | 360 |
|
2022
Q4 | $339K | Sell |
1,630
-203
| -11% | -$42.3K | 0.04% | 359 |
|
2022
Q3 | $400K | Buy |
1,833
+32
| +2% | +$6.98K | 0.04% | 311 |
|
2022
Q2 | $433K | Buy |
1,801
+582
| +48% | +$140K | 0.04% | 318 |
|
2022
Q1 | $296K | Buy |
1,219
+80
| +7% | +$19.4K | 0.03% | 408 |
|
2021
Q4 | $297K | Buy |
1,139
+48
| +4% | +$12.5K | 0.03% | 384 |
|
2021
Q3 | $288K | Buy |
1,091
+30
| +3% | +$7.92K | 0.03% | 371 |
|
2021
Q2 | $262K | Sell |
1,061
-144
| -12% | -$35.6K | 0.03% | 421 |
|
2021
Q1 | $234K | Sell |
1,205
-222
| -16% | -$43.1K | 0.02% | 438 |
|
2020
Q4 | $303K | Buy |
1,427
+41
| +3% | +$8.71K | 0.03% | 325 |
|
2020
Q3 | $238K | Sell |
1,386
-164
| -11% | -$28.2K | 0.03% | 356 |
|
2020
Q2 | $298K | Buy |
1,550
+85
| +6% | +$16.3K | 0.04% | 296 |
|
2020
Q1 | $216K | Buy |
1,465
+92
| +7% | +$13.6K | 0.02% | 313 |
|
2019
Q4 | $213K | Buy |
+1,373
| New | +$213K | 0.03% | 393 |
|
2016
Q3 | – | Sell |
-828
| Closed | -$52K | – | 1016 |
|
2016
Q2 | $52K | Buy |
828
+182
| +28% | +$11.4K | 0.01% | 814 |
|
2016
Q1 | $37K | Buy |
+646
| New | +$37K | 0.01% | 915 |
|